- Home
- PTHL vs RAPT Comparison
PTHL vs RAPT Comparison
Compare PTHL & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTHL
- RAPT
- Stock Information
- Founded
- PTHL 1998
- RAPT 2015
- Country
- PTHL China
- RAPT United States
- Employees
- PTHL N/A
- RAPT N/A
- Industry
- PTHL
- RAPT Biotechnology: Pharmaceutical Preparations
- Sector
- PTHL
- RAPT Health Care
- Exchange
- PTHL Nasdaq
- RAPT Nasdaq
- Market Cap
- PTHL 65.0M
- RAPT 65.6M
- IPO Year
- PTHL 2024
- RAPT 2019
- Fundamental
- Price
- PTHL $4.35
- RAPT $1.11
- Analyst Decision
- PTHL
- RAPT Hold
- Analyst Count
- PTHL 0
- RAPT 10
- Target Price
- PTHL N/A
- RAPT $5.00
- AVG Volume (30 Days)
- PTHL 150.0K
- RAPT 995.1K
- Earning Date
- PTHL 11-26-2024
- RAPT 11-12-2024
- Dividend Yield
- PTHL N/A
- RAPT N/A
- EPS Growth
- PTHL N/A
- RAPT N/A
- EPS
- PTHL N/A
- RAPT N/A
- Revenue
- PTHL $572,291.00
- RAPT N/A
- Revenue This Year
- PTHL N/A
- RAPT N/A
- Revenue Next Year
- PTHL N/A
- RAPT N/A
- P/E Ratio
- PTHL N/A
- RAPT N/A
- Revenue Growth
- PTHL 2.32
- RAPT N/A
- 52 Week Low
- PTHL $3.32
- RAPT $1.03
- 52 Week High
- PTHL $6.45
- RAPT $27.35
- Technical
- Relative Strength Index (RSI)
- PTHL N/A
- RAPT 33.55
- Support Level
- PTHL N/A
- RAPT $1.31
- Resistance Level
- PTHL N/A
- RAPT $1.96
- Average True Range (ATR)
- PTHL 0.00
- RAPT 0.39
- MACD
- PTHL 0.00
- RAPT -0.14
- Stochastic Oscillator
- PTHL 0.00
- RAPT 3.28
About PTHL Pheton Holdings Ltd Class A Ordinary Shares
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.